| Literature DB >> 28360869 |
Pauline Dibbets1, Elisabeth A T Evers1.
Abstract
Formal theories have linked pathological anxiety to a failure in fear response inhibition. Previously, we showed that aberrant response inhibition is not restricted to anxiety patients, but can also be observed in anxiety-prone adults. However, less is known about the influence of currently experienced levels of anxiety on inhibitory learning. The topic is highly important as state anxiety has a debilitating effect on cognition, emotion, and physiology and is linked to several anxiety disorders. In the present study, healthy female volunteers performed a fear conditioning task, after being informed that they will have to perform the Trier Social Stress Test task (n = 25; experimental group) or a control task (n = 25; control group) upon completion of the conditioning task. The results showed that higher levels of state anxiety corresponded with a reduced discrimination between a stimulus (CS+) typically followed by an aversive event and a stimulus (CS-) that is never followed by an aversive event both during the acquisition and the extinction phase. No effect of state anxiety on the skin conductance response associated with CS+ and CS- was found. Additionally, higher levels of state anxiety coincided with more negative valence ratings of the CSs. The results suggest that increased stress-induced state anxiety might lead to stimulus generalization during fear acquisition, thereby impairing associative learning.Entities:
Keywords: extinction; fear conditioning; inhibition; state anxiety; stress
Year: 2017 PMID: 28360869 PMCID: PMC5352667 DOI: 10.3389/fpsyg.2017.00347
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Demographic information and mean scores (SDs) and range on the questionnaires (for the whole groups, i.e., across conditions)∗.
| Score ( | Range | |
|---|---|---|
| Age | 21.82 (1.96) | 18.67–26.17 |
| PRCA | 15.78 (5.21) | 6–29 |
| STAIT | 33.60 (7.47) | 21–57 |
| STAIS | ||
| STAIS#1 | 32.10 (6.34) | 20–49 |
| STAIS#2 | 30.99 (7.15) | 21–53 |
| STAIS#3 | 38.24 (8.60) | 25–64 |
| STAIS#4 | 32.32 (8.56) | 20–66 |
| mDES positive items | ||
| mDESpos#1 | 20.92 (3.54) | 13–28 |
| mDESpos#2 | 20.48 (3.90) | 11–29 |
| mDESpos#3 | 18.53 (4.48) | 5–27.50 |
| mDESpos#4 | 19.54 (5.15) | 5–29 |
| mDES negative items | ||
| mDESneg#1 | 11.42 (3.23) | 8–22 |
| mDESneg#2 | 11.13 (3.68) | 8–25 |
| mDESneg#3 | 14.21 (5.65) | 8–39 |
| mDESneg#4 | 11.56 (5.97) | 8–39 |
| mDES stress item | ||
| mDESstress#1 | 2.26 (1.14) | 1–5 |
| mDESstress#2 | 2.42 (1.47) | 1–6 |
| mDESstress#3 | 3.35 (1.59) | 1–7 |
| mDESstress#4 | 2.10 (1.34) | 1–6 |
| Stimulus ratings baseline | ||
| CS+ valence | 38.74 (13.71) | 0–67 |
| CS+ safety | 45.96 (18.23) | 4–82 |
| CS- valence | 38.02 (12.75) | 6–56 |
| CS- safety | 45.26 (16.70) | 8–80 |
| US valence | 12.74 (10.47) | 0–48 |
| US arousal | 32.26 (22.66) | 0–92 |
| Stimulus ratings post conditioning | ||
| CS+ valence | 20.84 (13.95) | 0–49 |
| CS+ safety | 21.43 (16.48) | 0–65 |
| CS- valence | 53.56 (20.74) | 1–84 |
| CS- safety | 62.04 (18.23) | 3–86 |
| US valence | 12.56 (14.42) | 0–51 |
| US change in arousal | 55.32 (22.15) | 0–100 |